SIGA Technologies, Inc. (SIGA) 은(는) 상장 기업입니다 헬스케어 섹터의 Drug Manufacturers - Specialty & Generic 산업에서 운영. 본사 소재지는 New York City, NY, 미국. 현재 CEO는 Diem Nguyen.
SIGA 을(를) 보유 IPO 날짜 1997-09-10, 46 명의 정규직 직원, 에 상장 NASDAQ Global Market, 시가총액 $336.73M.
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
